ReviewDrug design, development and therapy2015

Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.

Paolo Ricchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.